Literature DB >> 28321489

MicroRNA regulation and analytical methods in cancer cell metabolism.

Ling-Fei Zhang1,2,3, Shuai Jiang4, Mo-Fang Liu5,6,7.   

Abstract

The reprogramming of glucose metabolism from oxidative to glycolytic metabolism, known as the Warburg effect, is an anomalous characteristic of cancer cell metabolism. Recent studies have revealed a subset of microRNAs (miRNAs) that play critical roles in regulating the reprogramming of glucose metabolism in cancer cells. These miRNAs regulate cellular glucose metabolism by directly targeting multiple metabolic genes, including those encoding key glycolytic enzymes. In the first part of this review, we summarized the recent knowledge of miRNA regulation in the reprogramming of glucose metabolism in cancer cells and discussed the potential utilization of the key miRNA regulators as metabolic targets for developing new antitumor agents. Then, we summarized recent advances in methods and techniques for studying miRNA regulation in cancer cell metabolism.

Entities:  

Keywords:  Analytical strategies; Cancers; MicroRNAs; Reprogramming of glucose metabolism

Mesh:

Substances:

Year:  2017        PMID: 28321489     DOI: 10.1007/s00018-017-2508-y

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  115 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

Review 2.  MicroRNAs: small RNAs with a big role in gene regulation.

Authors:  Lin He; Gregory J Hannon
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

3.  Rapid diagnosis and prognosis of de novo acute myeloid leukemia by serum metabonomic analysis.

Authors:  Yihuang Wang; Limin Zhang; Wen-Lian Chen; Jing-Han Wang; Ning Li; Jun-Min Li; Jian-Qing Mi; Wei-Na Zhang; Yang Li; Song-Fang Wu; Jie Jin; Yun-Gui Wang; He Huang; Zhu Chen; Sai-Juan Chen; Huiru Tang
Journal:  J Proteome Res       Date:  2013-09-18       Impact factor: 4.466

4.  Usefulness of microRNA‑375 as a prognostic and therapeutic tool in esophageal squamous cell carcinoma.

Authors:  Yuka Isozaki; Isamu Hoshino; Yasunori Akutsu; Naoyuki Hanari; Mikito Mori; Takanori Nishimori; Kentaro Murakami; Naoki Akanuma; Nobuyoshi Takeshita; Tetsuro Maruyama; Takeshi Toyozumi; Masahiko Takahashi; Hiroshi Suito; Hisahiro Matsubara
Journal:  Int J Oncol       Date:  2014-12-09       Impact factor: 5.650

Review 5.  Tumor-specific positron emission tomography imaging in patients: [18F] fluorodeoxyglucose and beyond.

Authors:  David A Mankoff; Janet F Eary; Jeanne M Link; Mark Muzi; Joseph G Rajendran; Alexander M Spence; Kenneth A Krohn
Journal:  Clin Cancer Res       Date:  2007-06-15       Impact factor: 12.531

6.  miR-375 maintains normal pancreatic alpha- and beta-cell mass.

Authors:  Matthew N Poy; Jean Hausser; Mirko Trajkovski; Matthias Braun; Stephan Collins; Patrik Rorsman; Mihaela Zavolan; Markus Stoffel
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-16       Impact factor: 11.205

Review 7.  Lactate dehydrogenase A in cancer: a promising target for diagnosis and therapy.

Authors:  Ping Miao; Shile Sheng; Xiaoguang Sun; Jianjun Liu; Gang Huang
Journal:  IUBMB Life       Date:  2013-11-07       Impact factor: 3.885

8.  Regulation of Aerobic Glycolysis by microRNAs in Cancer.

Authors:  Pankaj K Singh; Kamiya Mehla; Michael A Hollingsworth; Keith R Johnson
Journal:  Mol Cell Pharmacol       Date:  2011

9.  MicroRNA-29B (mir-29b) regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3.

Authors:  Yue Teng; Yan Zhang; Kai Qu; Xinyuan Yang; Jing Fu; Wei Chen; Xu Li
Journal:  Oncotarget       Date:  2015-12-01

Review 10.  MicroRNAs and oncogenic transcriptional regulatory networks controlling metabolic reprogramming in cancers.

Authors:  Pannapa Pinweha; Khanti Rattanapornsompong; Varodom Charoensawan; Sarawut Jitrapakdee
Journal:  Comput Struct Biotechnol J       Date:  2016-06-04       Impact factor: 7.271

View more
  14 in total

1.  The miR-186-3p/EREG axis orchestrates tamoxifen resistance and aerobic glycolysis in breast cancer cells.

Authors:  Mengjia He; Qianni Jin; Cong Chen; Yifeng Liu; Xiangsen Ye; Yulin Jiang; Feihu Ji; Husun Qian; Delu Gan; Shujun Yue; Wei Zhu; Tingmei Chen
Journal:  Oncogene       Date:  2019-04-09       Impact factor: 9.867

Review 2.  How long noncoding RNAs enforce their will on mitochondrial activity: regulation of mitochondrial respiration, reactive oxygen species production, apoptosis, and metabolic reprogramming in cancer.

Authors:  Boel De Paepe; Steve Lefever; Pieter Mestdagh
Journal:  Curr Genet       Date:  2017-09-06       Impact factor: 3.886

Review 3.  Long non-coding RNAs involved in cancer metabolic reprogramming.

Authors:  Hui Liu; Junyun Luo; Siyu Luan; Chongsheng He; Zhaoyong Li
Journal:  Cell Mol Life Sci       Date:  2018-10-19       Impact factor: 9.261

Review 4.  Metabolic reprogramming results in abnormal glycolysis in gastric cancer: a review.

Authors:  Yuanda Liu; Ze Zhang; Junyang Wang; Chao Chen; Xiaohuan Tang; Jiaming Zhu; Jingjing Liu
Journal:  Onco Targets Ther       Date:  2019-02-13       Impact factor: 4.147

5.  Interplay Between Glucose Metabolism and Chromatin Modifications in Cancer.

Authors:  Rui Ma; Yinsheng Wu; Shanshan Li; Xilan Yu
Journal:  Front Cell Dev Biol       Date:  2021-04-27

Review 6.  One Omics Approach Does Not Rule Them All: The Metabolome and the Epigenome Join Forces in Haematological Malignancies.

Authors:  Antonia Kalushkova; Patrick Nylund; Alba Atienza Párraga; Andreas Lennartsson; Helena Jernberg-Wiklund
Journal:  Epigenomes       Date:  2021-10-08

7.  The expression of miR-513c and miR-3163 was downregulated in tumor tissues compared with normal adjacent tissue of patients with breast cancer.

Authors:  Soheila Delgir; Khandan Ilkhani; Asma Safi; Yazdan Rahmati; Vahid Montazari; Zahra Zaynali-Khasraghi; Farhad Seif; Milad Bastami; Mohammad Reza Alivand
Journal:  BMC Med Genomics       Date:  2021-07-07       Impact factor: 3.063

8.  MiR-3662 suppresses hepatocellular carcinoma growth through inhibition of HIF-1α-mediated Warburg effect.

Authors:  Zhiqiang Chen; Xueliang Zuo; Yao Zhang; Guoyong Han; Long Zhang; Jindao Wu; Xuehao Wang
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

9.  rs61991156 in miR-379 is associated with low capability of glycolysis of gastric cancer by enhanced regulation of PKM2.

Authors:  Na Cao; Meng Li; Jun Han; Yongren Wang; Xiaowei Wang
Journal:  Cancer Cell Int       Date:  2018-07-04       Impact factor: 5.722

10.  Polo-like kinase 3 inhibits glucose metabolism in colorectal cancer by targeting HSP90/STAT3/HK2 signaling.

Authors:  Baochi Ou; Hongze Sun; Jingkun Zhao; Zhuoqing Xu; Yuan Liu; Hao Feng; Zhihai Peng
Journal:  J Exp Clin Cancer Res       Date:  2019-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.